Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 13/20 | 0.72 |
| ▸ | MAOA | P21397 | 12/20 | 0.72 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.67 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.64 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.55 |
| ▸ | HTR2A | P28223 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.55 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6170788 | 1.00 | MAOB (0.72) | MAOBMAOASPHK1SCN3AS1PR1 | |
| SCHEMBL6167507 | 0.87 | MAOB (0.79) | MAOBMAOASPHK1SCN3AS1PR1 | |
| SCHEMBL6167500 | 0.87 | MAOB (0.79) | MAOBMAOASPHK1SCN3AS1PR1 | |
| SCHEMBL26009688 | 0.84 | MAOB (0.78) | MAOBMAOASPHK1SCN3A | |
| SCHEMBL6171245 | 0.84 | MAOB (0.74) | MAOBMAOASPHK1SCN3AS1PR1 | |
| SCHEMBL6168425 | 0.84 | MAOB (1.00) | MAOBMAOASPHK1SCN3A | |
| SCHEMBL6171239 | 0.84 | MAOB (0.74) | MAOBMAOASPHK1SCN3AS1PR1 | |
| SCHEMBL6168433 | 0.84 | MAOB (1.00) | MAOBMAOASPHK1SCN3A | |
| SCHEMBL6168080 | 0.83 | SPHK1 (0.68) | MAOBMAOASPHK1SCN3AHRH3 | |
| SCHEMBL6168088 | 0.83 | SPHK1 (0.68) | MAOBMAOASPHK1SCN3AHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005040108-A1 | PROLINAMIDE DERIVATIVES AS SODIUM AND/OR CALCIUM CHANNEL BLOCKERS OR SELECTIVE MAO-B INHIBITORS | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-05-06 | — | — | WO | claimed |
| EP-1524265-A1 | Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors | Newron Pharmaceuticals S.p.A. (IT) | 2005-04-20 | — | — | EP | claimed |
| WO-2005040108-A1 | PROLINAMIDE DERIVATIVES AS SODIUM AND/OR CALCIUM CHANNEL BLOCKERS OR SELECTIVE MAO-B INHIBITORS | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-05-06 | — | — | WO | disclosed |
| EP-1524265-A1 | Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors | Newron Pharmaceuticals S.p.A. (IT) | 2005-04-20 | — | — | EP | disclosed |